BACKGROUND: Acute aortic dissection is a preventable life-threatening condition. However, there have been no prospective population-based studies of incidence or outcome to inform an understanding of risk factors, strategies for prevention, or projections for future clinical service provision. METHODS AND RESULTS: We prospectively determined incidence and outcomes of all acute aortic dissections in a population of 92 728 in Oxfordshire, United Kingdom, from 2002 to 2012. Among 155 patients with 174 acute aortic events, 54 patients had 59 thoracoabdominal aortic dissections (52 incident events: 6/100 000, 95% confidence interval, 4-7; 37 Stanford type A, 15 Stanford type B; 31 men, mean age=72.0 years). Among patients with type A incident events, 18 (48.6%) died before hospital assessment (61.1% women). The 30-day fatality rate was 47.4% for patients with type A dissections who survived to hospital admission and 13.3% for patients with type B dissections, although subsequent 5-year survival rates were high (85.7% for type A; 83.3% for type B). Even though 67.3% of patients were on antihypertensive drugs, 46.0% of all patients had at least 1 systolic BP ≥180 mm Hg in their primary care records over the preceding 5 years, and the proportion of blood pressures in the hypertensive range (>140/90 mm Hg) averaged 56.0%. Premorbid blood pressure was higher in patients with type A dissections that were immediately fatal than in those who survived to admission (mean/standard deviation pre-event systolic blood pressure=151.2/19.3 versus 137.9/17.9; P<0.001). CONCLUSIONS: Uncontrolled hypertension remains the most significant treatable risk factor for acute aortic dissection. Prospective population-based ascertainment showed that hospital-based registries will underestimate not only incidence and case fatality, but also the association with premorbid hypertension.
BACKGROUND: Acute aortic dissection is a preventable life-threatening condition. However, there have been no prospective population-based studies of incidence or outcome to inform an understanding of risk factors, strategies for prevention, or projections for future clinical service provision. METHODS AND RESULTS: We prospectively determined incidence and outcomes of all acute aortic dissections in a population of 92 728 in Oxfordshire, United Kingdom, from 2002 to 2012. Among 155 patients with 174 acute aortic events, 54 patients had 59 thoracoabdominal aortic dissections (52 incident events: 6/100 000, 95% confidence interval, 4-7; 37 Stanford type A, 15 Stanford type B; 31 men, mean age=72.0 years). Among patients with type A incident events, 18 (48.6%) died before hospital assessment (61.1% women). The 30-day fatality rate was 47.4% for patients with type A dissections who survived to hospital admission and 13.3% for patients with type B dissections, although subsequent 5-year survival rates were high (85.7% for type A; 83.3% for type B). Even though 67.3% of patients were on antihypertensive drugs, 46.0% of all patients had at least 1 systolic BP ≥180 mm Hg in their primary care records over the preceding 5 years, and the proportion of blood pressures in the hypertensive range (>140/90 mm Hg) averaged 56.0%. Premorbid blood pressure was higher in patients with type A dissections that were immediately fatal than in those who survived to admission (mean/standard deviation pre-event systolic blood pressure=151.2/19.3 versus 137.9/17.9; P<0.001). CONCLUSIONS: Uncontrolled hypertension remains the most significant treatable risk factor for acute aortic dissection. Prospective population-based ascertainment showed that hospital-based registries will underestimate not only incidence and case fatality, but also the association with premorbid hypertension.
Authors: R Erbel; F Alfonso; C Boileau; O Dirsch; B Eber; A Haverich; H Rakowski; J Struyven; K Radegran; U Sechtem; J Taylor; C Zollikofer; W W Klein; B Mulder; L A Providencia Journal: Eur Heart J Date: 2001-09 Impact factor: 29.983
Authors: W Darrin Clouse; John W Hallett; Hartzell V Schaff; Peter C Spittell; Charles M Rowland; Duane M Ilstrup; L Joseph Melton Journal: Mayo Clin Proc Date: 2004-02 Impact factor: 7.616
Authors: Arun Raghupathy; Christoph A Nienaber; Kevin M Harris; Truls Myrmel; Rossella Fattori; Udo Sechtem; Jae Oh; Santi Trimarchi; Jeanna V Cooper; Anna Booher; Kim Eagle; Eric Isselbacher; Eduardo Bossone Journal: Am J Cardiol Date: 2008-09-12 Impact factor: 2.778
Authors: Xue-Yan Duan; Dong-Chuan Guo; Ellen S Regalado; Hong Shen; Joseph S Coselli; Anthony L Estrera; Hazim J Safi; Michael J Bamshad; Deborah A Nickerson; Scott A LeMaire; Julie De Backer; Dianna M Milewicz Journal: Eur J Hum Genet Date: 2019-02-26 Impact factor: 4.246
Authors: Anne S Chin; Martin J Willemink; Aya Kino; Virginia Hinostroza; Anna M Sailer; Michael P Fischbein; R Scott Mitchell; Gerald J Berry; D Craig Miller; Dominik Fleischmann Journal: J Am Coll Cardiol Date: 2018-06-19 Impact factor: 24.094